Bolin Hou
Beijing, 100080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Perioperative hyperglycemia predicts poorer prognosis of esophageal squamous cell carcinoma patients treated with esophagectomy
Journal: Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
Published: June 13, 2026
Effects of blocking apoptosis and lactic acid metabolism pathways on robustness and foreign protein expression of CHO cells
Journal: Sheng wu gong cheng xue bao = Chinese journal of biotechnology
Published: August 28, 2025
Could higher hospital spending improve survival in patients with esophageal squamous cell carcinoma? A multicenter retrospective cohort study.
Journal: Frontiers in oncology
Published: July 17, 2025
Progression-Free Survival Prediction Model Based on AI-Enhanced Dynamic Radiomics for Personalized EGFR-TKI Treatment Monitoring Patients With Lung Adenocarcinoma.
Journal: Thoracic cancer
Published: December 25, 2024
The disulphide cleavage derivative (C42-4) of 11'-deoxyverticillin A (C42) fails to induce apoptosis and genomic instability in HeLa cells.
Journal: Mycology
Published: January 08, 2024
Community prevention and standardized clinical treatment jointly improve cancer outcome: Real-world evidence from an esophageal cancer patient cohort study.
Journal: Science bulletin
Published: December 11, 2023
Surgical quality determines the long-term survival superiority of right over left thoracic esophagectomy for localized esophageal squamous cell carcinoma patients: a real-world multicenter study.
Journal: International journal of surgery (London, England)
Published: September 02, 2023
Postoperative serum squamous cell carcinoma antigen and carcinoembryonic antigen predict overall survival in surgical patients with esophageal squamous cell carcinoma.
Journal: Frontiers in oncology
Published: July 20, 2023
Grb2 interacts with necrosome components and is involved in rasfonin-induced necroptosis.
Journal: Cell death discovery
Published: April 18, 2022
Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer From a Real-world Multicenter Study.
Journal: Annals of surgery
Published: February 07, 2022
The unique Akt inhibitor SC66 suppressed AMPK activity and abolished autophagy through the EGFR-p62 pathway.
Journal: Cell biology international
Published: August 24, 2021
Is Adjuvant Therapy a Better Option for Esophageal Squamous Cell Carcinoma Patients Treated With Esophagectomy? A Prognosis Prediction Model Based on Multicenter Real-World Data.
Journal: Annals of surgery
Published: June 06, 2021
Last Updated: 09/26/2026